Related by context. All words. (Click for frequent words.) 66 TRIOLEX HE# APOPTONE HE# 66 XL# anticancer compounds 66 delta gamma agonist 66 LymphoStat B belimumab 65 IMiDs R 65 Atripla combines 63 kidney urologic 63 fusion enhancers 63 CYT# potent vascular disrupting 63 oral nucleoside analogue 63 R sorafenib tablets 63 Pruvel TM 63 IMiDs ® 63 neuropathic pain metabolic diseases 63 small molecule thrombopoietin 63 Vidaza ® 63 Sustiva efavirenz 63 DP VPA 63 MediGene focuses 62 Vidaza R 62 candidates Azedra TM 62 psoriasis rheumatoid arthritis 62 Quinamed R 62 CYP#A# CYP#D# 62 ® bortezomib 62 certain protein tyrosine 62 triggers apoptosis programmed 62 metaglidasen 62 infectious diseases autoimmune diseases 62 neuropathic pain spasticity 61 Kosan dependence 61 commercialize CorMedix drug 61 inflammatory PDE 61 Nanobody R 61 Vytorin combines 61 oral immunomodulatory 61 TRAIL receptor antibodies 61 infectious diseases autoimmune 61 thalidomide Thalomid 61 NS5b 61 TLR9 agonists 61 evaluating satraplatin 61 MTP inhibitor 61 PI3K/Akt pathway inhibitor 61 DNA methyltransferase inhibitors 61 novel VDA molecule 61 telomerase therapeutic 61 Alfacell proprietary ribonuclease 61 IAP inhibitor 61 IMPDH inhibitor 61 non porcine pancreatic 61 XP# XP# 61 Panzem R 61 myelofibrosis polycythemia vera 61 unforeseen underperformance 60 hepatitis C lupus 60 products MKC# PP 60 commercializes implantable 60 HIV treatments Reyataz 60 Anidulafungin 60 treat refractory angina 60 systemic juvenile idiopathic 60 pralatrexate injection folate analogue 60 XOMA 3AB biodefense 60 peptidic compound 60 Long acting beta2 60 ALN PCS 60 Evoltra ® 60 cortisol synthesis 60 MSCRAMM ® 60 Pharma Merck Serono 60 artemisinin derivative 60 RAS MAPK pathway 60 novel emulsion formulation 60 small molecule glucokinase 60 Rigel R# 60 monoclonal antibody MAb 60 PrevOnco 60 erlotinib Tarceva ® 60 3TC lamivudine 60 agonistic human 60 candidate deforolimus 59 palonosetron hydrochloride Injection Dacogen 59 sulfonylhydrazine class 59 vinorelbine tartrate 59 Aplidin R 59 secretory phospholipase A2 59 commercializing oxidized glutathione 59 MKC# MT 59 CDK cyclin dependent 59 hypoxia selective 59 gastrin analogue TT 59 oral proteasome inhibitor 59 AAG geldanamycin analog 59 nucleoside analog 59 AKT inhibitor 59 TranSwitch indebtedness 59 vitamins minerals herbal 59 Fludara ® 59 M# rationally 59 orally administered inhibitor 59 R bortezomib 59 2 methoxyestradiol 59 protein tyrosine phosphatases 59 Initiates Enrollment 59 ritonavir boosted protease inhibitor 59 sapacitabine CYC# 59 rxRNA 59 THR beta agonist 59 HepDirect R 59 Merck OSI Pharmaceuticals 59 microtubule inhibitor 59 non nucleoside HCV 59 small molecule Hedgehog 59 oral Janus kinase 59 engineered proteases 59 Lenocta TM sodium stibogluconate 58 paclitaxel Taxol ® 58 neuronal nicotinic receptor NNR 58 IAP inhibitors 58 GVAX ® 58 HQK 58 oral prodrug 58 Albuferon albinterferon alfa 2b 58 Nanobody 58 Epothilones 58 MKC# MKC# PP 58 Ganciclovir 58 anti miRs antisense oligonucleotide 58 protein tyrosine phosphatase 1B 58 reverse transcriptase inhibitors 58 Monopril 58 regorafenib 58 ALS #-# 58 non nucleoside inhibitor 58 Aganocide 58 MKC# 58 5 HT2A serotonin 58 HCV polymerase inhibitors 58 volociximab 58 ADP receptor antagonist 58 RTP #i 58 multitargeted 58 Ceflatonin R 58 include Altastaph TM 58 CD4 monoclonal antibody 58 Incretin mimetics 58 oncolytic virus therapies 58 Delta opioid receptor 58 Maribavir 58 novel therapeutic antibodies 58 novel tubulin binding 58 humanized therapeutic 58 nucleoside analogs 58 platform HDL Mimetic 58 Sphingomab TM 58 dipeptidyl peptidase IV 58 proprietary BiTE ® 58 HepeX B TM 58 osteolytic bone disease 58 NS5B polymerase 58 Enhanze TM Technology 58 triple axel quad 58 PNP inhibitor 58 introduced NEUGENE 58 mda 7 58 CRTH2 58 TÎ ² 4 58 NU# direct 58 please visit http:/www.vandapharma.com 58 alpha folate receptor 58 cholesteryl ester transfer 58 Omacetaxine 58 signal transduction inhibitor 58 OXIGON TM 58 selective kinase inhibitor 57 Kosan proprietary 57 AEG# 57 oral anti arrhythmic 57 GSK '# 57 Darinaparsin 57 CD# CEA 57 tiapamil 57 semi synthetic lipoglycopeptide 57 Romidepsin 57 anti amnesic 57 PSN# [001] 57 anionic backbone 57 elotuzumab 57 CYT# vascular disrupting 57 MEK inhibitors 57 chemotherapeutic agents carboplatin 57 targeted anticancer therapies 57 Annamycin 57 Pazopanib 57 severe degenerative ischemic 57 HCV RNA polymerase 57 chimeric monoclonal antibody 57 sapropterin dihydrochloride Phase 57 Darinaparsin Zinapar TM 57 selective orally bioavailable 57 Locked Nucleic Acid 57 5 FU leucovorin 57 GW# [003] 57 Therapeutic Competitors Companies 57 Xcytrin R 57 Fleximer 57 Genotyping Test 57 HCV polymerase 57 selective A2A adenosine receptor 57 Sudhir Agrawal D.Phil 57 gastro intestinal inflammation 57 Saxagliptin 57 Submits NDA 57 epigenetic therapies 57 PEGylated interferon 57 lead molecular radiotherapeutic 57 virus HCV protease inhibitor 57 obj obj = 57 accumulate preferentially 57 antidiabetic 57 MCSP respectively 57 novel immunotherapies 57 proteasome inhibitor 57 TKB# 57 EOquin TM phase 57 PRN FDA Approves 57 TLR agonists 57 Muraglitazar 57 PrevOnco ™ 56 Antibody Drug Conjugate 56 RNA antagonists 56 SinuNase ™ 56 SPRYCEL ® 56 Modrenal R 56 YONDELIS 56 molecular therapeutics immunotherapies 56 Sphingomab 56 Darapladib 56 Solazed TM 56 developing Zerenex ferric 56 DGAT 56 Antigenics QS 56 Aganocide ® 56 targeted radiotherapeutic 56 selective estrogen receptor modulator 56 dimebon latrepirdine 56 acting fibrinolytic 56 affecting Amarin 56 VEGFR2 inhibitor 56 folate analogue metabolic 56 PDE4 56 Talabostat 56 ribonucleotide reductase clinically validated 56 IMiD 56 investigational compounds 56 auristatin 56 Submits Biologics License Application 56 potent antiproliferative 56 IgG1 monoclonal antibody 56 stavudine lamivudine 56 MAbs targeting 56 Voreloxin 56 polyglutamate 56 Trastuzumab DM1 56 ELND-#/AZD-# 56 liposomal formulation 56 Biogen Genentech 56 Tarmogen 56 Initiates Phase II 56 therapeutic monoclonal antibody 56 including eniluracil ADH 56 Novel Oral 56 ALTROPANE R 56 PDE4 inhibitor 56 drugs tenofovir lamivudine 56 motexafin gadolinium Injection 56 Oral NKTR 56 investigational humanized monoclonal antibody 56 sodium glucose cotransporter 56 activin receptor type 56 Receives Approvable Letter 56 Xanafide 56 mertansine 56 topical antifungal product 56 Archexin 56 targets HGF FGFR 56 Pancreate 56 attach auristatin 56 highly selective endothelin 56 Telik logo TELINTRA 56 Tß4 56 oral antiviral 56 AtuRNAi 56 Panzem NCD 56 TELINTRA R 55 immune modulatory 55 Adnectin 55 generation nucleoside analog 55 enhance ApoA 55 Humira adalimumab 55 Therapeutic Antibodies segment 55 STEDESA 55 orally inhaled migraine 55 inhibit oxidative stress 55 GSM GSM CDMA 55 CCR5 inhibitors 55 monoclonal antibody mAb 55 Azixa MPC 55 candidate REP# 55 RhuDex ® 55 Immunotherapeutic 55 Drug Shows Promise 55 Temsirolimus 55 Pharmos proprietary 55 antimitotic 55 antidumping rulings 55 IG HCR ;) CO 55 agonists antagonists 55 TLR7 agonist 55 Tesetaxel 55 PDX pralatrexate 55 taxane derivative 55 EndoTAG 55 chemotherapy hormonal therapy 55 anti atherothrombotic 55 Zalypsis 55 siRNA compounds 55 CORT # estimates 55 Sepracor patents 55 targeted antifolate 55 dasatinib Sprycel ® 55 pan HDAC inhibitor 55 aspirin clopidogrel 55 panitumumab Vectibix 55 clinically validated targets 55 Daclizumab 55 GPR# agonist 55 Unit Dose Budesonide 55 receptor tyrosine kinase inhibitor 55 delta opioid receptor 55 Epirubicin 55 HuLuc# 55 thiazolides 55 cyclin dependent kinase inhibitor 55 Locked Nucleic Acid LNA 55 proteins peptides 55 Ep CAM 55 HCV protease inhibitor 55 histone deacetylase HDAC 55 defensin mimetic antibiotic 55 immuno inflammatory diseases 55 DOS# 55 Aptamer 55 Completes Patient Enrollment 55 oral Factor Xa 55 Micromet proprietary BiTE 55 multi kinase inhibitor 55 Adenosine Therapeutics 55 vaccine adjuvants 55 5 HT2A inverse 55 selective serotonin 2C receptor 55 RON Notch 55 anti secretory 55 include Phenoptin TM 55 5 fluorouracil leucovorin 55 staphylococcal vaccines 55 lipid nanoparticle 55 anti CD3 monoclonal 55 anti botulism antibody 55 PDE# 55 Janus kinase 54 Erythropoietic therapies may 54 staphylococcal vaccine 54 sunitinib Sutent ® 54 pan histone deacetylase 54 apoptosis proteins 54 pathophysiological effects 54 molecularly targeted 54 synthetic anti infective 54 Aurora Kinase 54 Ecallantide 54 CD# monoclonal antibody 54 Aflibercept 54 patented Aganocide compounds 54 adenosine A2A 54 anti angiogenic agents 54 RAF kinase VEGFR 54 antihistamine decongestant 54 nucleoside analogues 54 NYSE Amex AEN 54 nucleoside reverse transcriptase inhibitors 54 foods insect stings 54 includes investigational compounds 54 #HT# 54 Receives Orphan Drug Designation 54 HCV protease inhibitors 54 Janus Kinase 54 MT#/MEDI-# 54 selective immunoproteasome inhibitor 54 compound perifosine 54 TO AVOID PREGNANCY WHILE 54 humanized interleukin 6 54 nucleotide analog 54 XOMA 3AB 54 IMC #B 54 metastatic colorectal 54 Stapled Peptide 54 TransVax ™ 54 HCD# [002] 54 sublingual tablet formulation 54 reverse transcriptase inhibitor 54 TLR9 agonist 54 Squalamine 54 Initiates Clinical Trial 54 CU NP 54 herpes simplex viruses 54 generation purine nucleoside 54 Meets Primary Endpoint 54 oral kinase inhibitor 54 receptor inhibiting monoclonal 54 GlycArt 54 Akt inhibitor 54 Trubion proprietary 54 cytomegalovirus CMV HAE 54 Onconase 54 M2 subunit 54 2 inhibitor CYT# 54 DiLA2 54 KSP inhibitor 54 histologies 54 Vegenics 54 IMA# 54 cyclophosphamide methotrexate 54 myasthenia gravis Huntington 54 tramiprosate Alzhemed TM 54 Gammagard Liquid 54 demonstrated antitumor activity 54 Submits Supplemental 54 chemoattractant receptors 54 PEGylated 54 Recombinant Human 54 Elacytarabine 54 AFREZZA TM 54 cyclophilin inhibitors 54 V#F mutation 54 Epidermal Growth Factor Receptor 54 AGS PSCA 54 Initiates Phase III 54 tumor vascular disrupting 54 lamivudine stavudine 54 Files IND 54 HER pathway 54 selective inverse agonist 54 beta lactamase inhibitor 54 BRAF kinase 54 potent cytotoxic 54 non thiazolidinedione TZD 54 Protein Kinase C 54 Granulocyte Colony Stimulating Factor 54 midstage clinical 54 includes TOLAMBA TM 54 HepDirect 54 receptor modulators 54 ChronVac C R 54 5 HT6 receptor 54 sodium glucose transporter 53 triciribine phosphate monohydrate 53 stavudine d4T 53 VIOXX Product 53 cetuximab Erbitux R 53 Thiarabine 53 Idera Pharmaceuticals 53 SAR# [002] 53 using VIAdel TM 53 INxin TM 53 deforolimus 53 Aliskiren 53 inhibitor COX 53 Imatinib mesylate 53 humanized antibodies 53 explosives hexamethylene triperoxide diamine 53 bioactive lipids 53 HepDirect prodrug 53 Maxy G# 53 Homspera TM 53 Intravenous CP 53 Orally administered 53 AdVac ® 53 DEB# 53 Symbicort combine 53 Pertuzumab 53 alkylated amino acid 53 delta isoform 53 Fc fusion protein 53 ddRNAi 53 anticancer therapeutics 53 hydrophobic docetaxel prodrug nanoparticle 53 NRTI backbone 53 peptibody 53 pneumonia encephalitis 53 projectors VCRs 53 Nasulin ™ 53 molecular imaging radiopharmaceutical 53 imatinib Gleevec ® 53 TRO# 53 Protease inhibitors 53 drug conjugate 53 LogicVision disclaims 53 nitric oxide donating prostaglandin 53 humanized monoclonal antibodies 53 microsomal triglyceride transfer 53 bevacizumab Avastin ® 53 cathepsin K inhibitor 53 containing abacavir 53 Achieves Primary Endpoint 53 Factor VIIa 53 erlotinib Tarceva 53 potently inhibit 53 Company noncontributory defined 53 seliciclib CYC# 53 antibody trastuzumab 53 small molecule tyrosine 53 quinoline 53 Systemic Delivery 53 apricitabine ATC 53 siRNA sequences 53 B lymphocyte stimulator 53 Leuprolide 53 immunomodulatory 53 intra arterial chemotherapy 53 compound PMX # 53 MEK inhibitor 53 JAK2 inhibitor 53 adecatumumab MT# 53 Olaparib 53 PKC# 53 JAK2 Inhibitor 53 Receives Milestone Payment 53 Cyclosert 53 ENMD # 53 protein kinase inhibitors 53 γ secretase 53 polysaccharide polymer 53 mucus plugging 53 Presents Preclinical 53 HGS ETR2 53 Nexavar sorafenib 53 NNRTIs 53 TNF alpha selectively neutralizing 53 Gleevec resistant 53 replicon 52 EGFR HER2 52 stranded LNA 52 outlicensed 52 human influenzas 52 Rindopepimut 52 biobetter 52 Vaxfectin 52 AZT zidovudine 52 intranasal formulation 52 tumor suppressors cytokines 52 opiates muscle relaxants 52 Presents Preclinical Data 52 Xanthus Pharmaceuticals Inc. 52 alkylating 52 APPY believes 52 Candente relies upon 52 histone deacetylase HDAC inhibitor 52 5 HT2C 52 demethylating agent 52 CDDO Im 52 highly selective adenosine 52 HSP# inhibitors 52 SUPPRELIN LA DELATESTRYL 52 fibrate drugs 52 integrase inhibitors 52 PEG irinotecan 52 Taxol ® 52 reversible inhibitors 52 OncoVex 52 Angiocept 52 PORxin TM 52 AMPK activators 52 SearchHelp communications 52 protein kinase inhibitor 52 3p siRNAs 52 including calcitonin PTH 52 Hsp# Inhibitor 52 HSP# inhibitor 52 APNB believes 52 AFRESA ® 52 sorafenib Nexavar 52 oral JAK1 52 factors APPY 52 factor Xa 52 microRNA assays 52 Tumour Vascular Disrupting Agent 52 Anticalins 52 A3 adenosine receptor 52 Cathepsin S 52 Factor Receptor 52 KRAS mutant 52 polymerase inhibitors 52 drawing painting gouache 52 Fibroblast Growth Factor Receptor 52 Pathway Inhibitor 52 PEGylated Fab fragment 52 chemotherapeutic agent doxorubicin 52 PAION AG ISIN 52 endogenous ligands 52 Glucagon Like Peptide 52 OXi# 52 AFREZZA ™ 52 R roscovitine 52 chemokine receptor 52 vascular disrupting agent 52 JAK inhibitors 52 Y2 receptor 52 peptidomimetic 52 brivanib 52 OMP #R# 52 ALN VSP Phase 52 HuCAL antibody 52 selective antagonist 52 painful rocklike scar tissue 52 MT# MEDI 52 regarding Heska 52 selective phosphodiesterase 52 investigational protease inhibitor 52 dopamine D2 52 delipidation 52 carbohydrate polymer 51 siRNA therapeutic 51 Submits IND 51 PSN# [002] 51 Cotara ® 51 vidofludimus 51 alpha#beta# 51 CNS Disorders 51 IIB ActRIIB 51 directed radiotherapeutic antibody 51 siRNA antisense 51 risksassociated 51 humanized monoclonal antibody 51 PDGFR B 51 inhaled formulation 51 Umbilical cord stem cells 51 serine proteases 51 Kinase Inhibitor 51 novel orally bioavailable 51 MTHFD1L gene 51 Contramid R 51 Drug Candidate 51 includes ecallantide recombinant 51 cause salmonellosis foodborne 51 proteasome inhibitors 51 Phosphodiesterase 51 vitro pharmacology 51 FLT3 51 beta 1a 51 interferon lambda 51 5 HT2A receptor 51 ASONEP ™ 51 biased ligand 51 Inotek Pharmaceuticals Corporation 51 highly selective inhibitor 51 TLR9 agonist IMO 51 TREANDA 51 Cytotoxic 51 targeting CD# 51 5 HT4 51 Dose Escalation 51 Reports Preclinical Data 51 nilotinib Tasigna 51 PF # [002] 51 using Crucell PER.C6 51 mediated autoimmune diseases 51 selective inhibition 51 5 HT6 51 anticancer compounds 51 radiation sensitizer 51 Catalyst Biosciences 51 thrombopoietin TPO 51 novel peptide 51 Initiates Phase 2b 51 candidate iSONEP TM 51 enzyme inhibitors 51 antibody cytokine 51 Tumor Necrosis Factor 51 Interferon alfa 51 selectively inhibit 51 phosphoinositide 3 51 TransVax tm 51 epoetin zeta 51 Begins Dosing 51 methionine aminopeptidase 51 recombinant antibodies 51 TNF á 51 Adenosine A2A 51 initiated Phase Ib 51 c Relates 51 MGd 51 PI3K AKT 51 immunotherapeutic 51 2A receptor agonist 51 selective adenosine 51 antiangiogenic agents 51 anti fungals 51 PLK1 SNALP 51 SGLT 2 51 pyrimidine 50 liposomal formulations 50 novel orally administered 50 selectin antagonist 50 peripherally restricted 50 drug monomethyl auristatin 50 hyaluronidase enzyme 50 CYP#D# gene 50 prodrugs 50 selective modulator 50 TRIM5a 50 Initiates Clinical 50 agonist compounds 50 #HT#A 50 neurokinin 1 50 Tesmilifene 50 Idera Pharmaceuticals develops 50 antibody fragment therapeutics 50 homocysteine assay 50 ImmunoVEX 50 TLR8 50 Yamanaka recipe 50 5 HT2A 50 impacting WesBanco 50 mitogen activated ERK kinase 50 mitotic kinesin 50 humanized monoclonal 50 Darinaparsin ZIO 50 mGluR2 NAM 50 JAK inhibitor 50 GPR# agonists 50 proprietary LNA 50 Initiate Phase 50 Monoclonal 50 immunotoxin 50 Nasdaq MITI biopharmaceutical 50 standard chemotherapy regimens 50 JZP 50 dependent cellular cytotoxicity 50 thrombopoietin 50 negative allosteric modulator 50 Vilazodone 50 epothilones 50 N acetylgalactosamine 50 vascular disrupting agents 50 anemias 50 poly ADP ribose polymerase 50 shares Stammaktien 50 5 HT2C serotonin 50 antibody MT# 50 humanized antibody 50 Amylin disclaims 50 novel histone deacetylase 50 Receptor TLR 50 Irinotecan 50 alpha#beta# integrin 50 cyclin dependent kinase CDK 50 MMAE 50 SGLT2 inhibitor 50 Preclinical studies suggest 50 immunostimulatory 50 cytokine refractory 50 inverse agonist 50 tyrosine kinase inhibitor 50 reformulates existing FDA 50 Angiotensin Converting Enzyme 50 PANVAC VF 50 tubulin inhibitors 50 small molecule macrocyclic 50 JAK1 50 Nasdaq IDRA today 50 Inc. Nasdaq NEXM 50 Phase 2a Clinical Trial 50 nucleosides 50 #.#.# ordinary 50 Surface Specialties acquisition 50 benzimidazole 50 TRAIL receptor 50 albumin naturally occurring 50 peptides proteins 50 siRNAs targeting 50 targets Galectin receptors 50 VentiRx Pharmaceuticals 50 Liposomal 50 Ixabepilone 50 kinesin spindle protein KSP 50 WCDMA HSPA + 50 NEUGENE antisense 50 FERC MPSC NRC 50 OMP #M# 50 alpha 2A adrenergic 50 p# MAP kinase 50 combinability 50 small molecule activators 50 prostaglandin D2 50 Vascular Endothelial Growth 50 Tyrosine Kinase Inhibitor 50 oral hypoglycemic agents 50 Histone Deacetylase 50 aspirin statin 50 Decitabine 49 HCV antiviral 49 HER1 49 Antigen Specific 49 Irritability anxiety cognitive 49 peptide antigens 49 BiTE 49 Verint Systems Inc 49 botulism antibody 49 TBC M4 49 racemic mixture 49 Signaling Pathway 49 oncolytic 49 activate SIRT1 49 FierceGovernmentIT tracks 49 GPCR targets 49 HDACi 49 c myc gene 49 coughing sneezing runny nose 49 Luteinizing Hormone Releasing Hormone 49 chemopreventive agents 49 GVAX R 49 HyperAcute 49 selectively inhibited 49 Files Investigational 49 antiviral compounds 49 CYC# 49 isoform selective 49 hepatoma 49 K#N 49 Protease Inhibitor 49 Commences Phase 49 Degarelix 49 immune modulator 49 isotypes 49 IMAGE utilizes 49 lead compound ISA# 49 IgG1 49 market fluctuations investee 49 soluble tumor necrosis 49 pyrimidines 49 immune stimulatory 49 Enzastaurin 49 5 FU cytotoxic 49 XGen Nevis Island 49 Phase 2b Clinical Trial 49 anthracycline derivative 49 therapeutic regimens 49 Pivotal Phase 49 VIOXX Lawsuits 49 aurora kinase 49 preclinical xenograft models 49 drug conjugates ADCs 49 ErbB1 49 AFREZZA ® 49 EnVivo Pharmaceuticals Inc. 49 b Excludes 49 integrative pharmacology 49 SGLT inhibitors 49 Lung Cancer Drug 49 adenovirus serotype 49 Vaxfectin R 49 polyclonal antibody 49 VaxInnate proprietary 49 Juvaris BioTherapeutics 49 SynCon 49 Adjuvanted 49 citrus zests 49 multiple sclerosis muscular dystrophy 49 phage display libraries 49 ispinesib SB # 49 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 49 PROfusion 49 Chemokine 49 motesanib diphosphate 49 FGFR 49 antisense compounds 49 PEG SN# 49 Randomized Phase 49 sphingosine 1 49 tyrosine kinase receptor 49 receptor inhibitor 49 Concateno plc 49 synthetic siRNAs 49 nicotinic alpha 7 49 receptors PPARs 48 ZFP technology 48 gonadotrophin releasing hormone GnRH 48 cMet 48 sunscreen bug repellent 48 humanized anti 48 VEGF receptor 48 Alvine Pharmaceuticals Inc. 48 prepayment speeds loan originations 48 SynCon TM DNA 48 muscarinic 48 antisense inhibitor 48 Apoptone HE# 48 vinblastine 48 deacetylase 48 excludes unrealized gains 48 Inegy 48 geldanamycin 48 Peroxisome Proliferator Activated Receptor 48 IMC A# 48 receptor partial agonist 48 cell adhesion molecule 48 Monoclonal Antibody 48 MAb 48 synthetic peptides 48 cerebral palsy Asperger syndrome 48 Flt3 48 Initiates Phase 48 aspirin statins 48 Small Molecule 48 NPC 1C 48 PI3 Kinase 48 receptor PPAR 48 xenograft models 48 antitumour 48 HMGCR 48 selective inhibitors 48 agent bevasiranib 48 DepoVax TM 48 alpha hydroxyl acids 48 kinase inhibition 48 andrelated 48 topoisomerase II inhibitor 48 S#P# 48 SynCon ™ DNA 48 strategic alliances divestitures 48 Lavigne cited irreconcilable 48 sublease recoveries 48 lysophosphatidic acid LPA 48 polyketides 48 short interfering RNA 48 peroxisome proliferator activated 48 Anticancer Compound 48 Plasmid DNA 48 adopting SFAS #R 48 Angiotensin 48 Acorda Therapeutics intellectual property 48 retinoic acid receptor 48 interleukin IL -# 48 Inc. Nasdaq MITI 48 Aloe Vera juice 48 MET VEGFR2 48 antifolates 48 selective inhibitor 48 applies prospectively 48 agonist antagonist 48 LRRK2 gene 48 CB2 receptor selective 48 HDAC Inhibitor 48 hpSCs avoid ethical 48 potent anticancer 48 Exherin 48 Agreement constitutes discloseable 48 small molecule modulators 48 MLL gene 48 potent suppressor 48 Coming Biotech Boom 48 aluminum hydroxide adjuvant 48 macrocycles 48 molecules Immune SIMULATORS 48 retroviral vectors 48 Bioenvision dependence 48 contingent guaranties 48 Sphingosine 1 48 Tumor necrosis factor 48 b Relates 48 effector function 47 lipid nanoparticles 47 vesicular monoamine transporter 47 ABCB1 gene 47 merchant chargebacks 47 uncertainties materialize Shire plc 47 bioactives 47 TLR7 pathway 47 pyrimidine analogs 47 alleges fraudulent misrepresentations 47 Cooked tomatoes 47 joint ventures strategic alliances 47 duplex siRNA 47 somatostatin 47 HCV protease 47 Small Modular SMIP 47 ProMune